// Auto-generated search index - do not edit
const SEARCH_INDEX = [
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-08-13\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often ",
    "url": "./specification.html",
    "section": "Core Specification",
    "keywords": "PURPOSE PATCH INFRINGE MHC EBI HEREIN USE DOID collision energy disease THAT STANDARDS ... characteristics MS:1001251 CT proteomics data acquisition method reduction reagent PRIDE:0000659 RECOMMENDED LC SN SILAC technical replicate FOR README III TMT PRM ENVO NCE EFO DDA PROTEOMICS TA PS spiked compound XL TO SWATH CS WARRANTY OR CN URI NT TIP FITNESS REQUIRED IMPORTANT developmental stage PSI DISCLAIMS IMPLIED instrument MAY PMID SHALL alkylation reagent HTML COLUMN BUT FDR CPTAC SDRF IDF CF NOT MUST ANY ID PARTICULAR ISA XML PMCID PATO CELL source name MT pooled sample fraction identifier SP DJ CLO INCLUDING CV QY MERCHANTABILITY CL EXPRESS SHOULD HF IS sex source name_ and _assay name OF ALL biological replicate BTO AS MAJOR MAGE COULD EW individual EM VCF RECOMMEND PRIDE PP LI WARRANTIES LIMITED file your organism MS cell type MIAME OPTIONAL PEPTIDESEQ THE MC REQUIRES MOD ZFA label TAB BE disease stage mass replicate NOTE AC dissociation method CID SRM PTM BMC biosample accession number MINOR RIGHTS IAA age exclamation DTT INITIATIVE RAW URL ancestry category SH ROW HANCESTRO RFC data file fractionation method MANDATORY DIA MONDO depletion HUPO sample VK JA organism part cleavage agent details II NCBI BRENDA UBERON INFORMATION WILL PO HCD"
  },
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-08-13\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often ",
    "url": "./specification.html#sample-and-data-relationship-format-for-proteomics-sdrf-proteomics",
    "section": "Core Specification",
    "keywords": "PURPOSE PATCH INFRINGE MHC EBI HEREIN USE DOID collision energy disease THAT STANDARDS ... MS:1001251 CT proteomics data acquisition method reduction reagent PRIDE:0000659 RECOMMENDED LC SN SILAC technical replicate FOR README III TMT PRM ENVO NCE EFO DDA PROTEOMICS TA PS spiked compound XL TO SWATH CS WARRANTY OR CN URI NT FITNESS REQUIRED PSI DISCLAIMS IMPLIED instrument MAY PMID SHALL alkylation reagent HTML COLUMN BUT FDR CPTAC SDRF IDF CF NOT MUST ANY PARTICULAR ISA PMCID PATO CELL MT pooled sample fraction identifier SP DJ CLO INCLUDING CV QY MERCHANTABILITY CL EXPRESS SHOULD HF IS sex OF ALL biological replicate BTO AS MAJOR MAGE COULD EW individual EM VCF RECOMMEND PRIDE PP LI WARRANTIES LIMITED organism MS cell type MIAME OPTIONAL PEPTIDESEQ THE MC REQUIRES MOD ZFA label TAB BE disease stage mass AC dissociation method CID SRM PTM BMC biosample accession number MINOR RIGHTS IAA age DTT INITIATIVE RAW URL ancestry category SH ROW HANCESTRO RFC data file fractionation method MANDATORY DIA MONDO depletion HUPO VK JA organism part cleavage agent details II NCBI BRENDA UBERON INFORMATION WILL PO HCD"
  },
  {
    "title": "Sample Metadata Conventions",
    "content": "Sample Metadata Conventions\n\nStatus of this Convention\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These conventions apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata conventions define standardized formats for common properties that apply across all organism types. This convention covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Convention.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSk",
    "url": "./conventions/sample-metadata.html",
    "section": "Sample Metadata Convention",
    "keywords": "CL:0000576 compound PATO:0000384 CML MONDO:0100096 DOID disease CL:0000235 UBERON:0001155 MONDO:0004975 MONDO:0005301 MONDO:0004946 CL:0000787 PATO:0001340 MONDO:0005148 CL:0000057 EFO NSG UBERON:0002048 CL:0000232 PDX CSF TIP CL:0000182 APP IMPORTANT CL:0000236 developmental stage CL:0000233 MAY CL:0000624 enrichment process UBERON:0002097 MONDO:0005575 DSS UBERON:0000310 CL:0000625 SDRF CL:0000066 CL:0000623 CL:0000788 MUST ID UBERON:0001969 PATO source name UBERON:0000955 UBERON:0000948 disease model CL CL:0000084 MONDO:0008383 SHOULD UBERON:0001977 sex PATO:0000383 ALL biological replicate CL:0000813 individual synthetic peptide CL:0000540 UBERON:0002113 CL:0000898 COVID organism cell type CL:0000815 UBERON:0001088 MONDO:0005138 NOTE PTM age MONDO:0005105 UBERON:0001359 exclamation URL PATO:0000461 ancestry category HANCESTRO lib MONDO:0005180 CL:0000913 UBERON:0002107 depletion MONDO organism part xenograft CL:0000451 NCBI UBERON UBERON:0000178 MONDO:0004989 PO NK"
  },
  {
    "title": "Sample Metadata Conventions",
    "content": "Sample Metadata Conventions\n\nStatus of this Convention\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These conventions apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata conventions define standardized formats for common properties that apply across all organism types. This convention covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Convention.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSk",
    "url": "./conventions/sample-metadata.html#sample-metadata-conventions",
    "section": "Sample Metadata Convention",
    "keywords": "CL:0000576 compound PATO:0000384 CML MONDO:0100096 DOID disease CL:0000235 UBERON:0001155 MONDO:0004975 MONDO:0005301 MONDO:0004946 CL:0000787 PATO:0001340 MONDO:0005148 CL:0000057 EFO NSG UBERON:0002048 CL:0000232 PDX CSF CL:0000182 APP CL:0000236 developmental stage CL:0000233 MAY CL:0000624 enrichment process UBERON:0002097 MONDO:0005575 DSS UBERON:0000310 CL:0000625 SDRF CL:0000066 CL:0000623 CL:0000788 MUST ID UBERON:0001969 PATO source name UBERON:0000955 UBERON:0000948 disease model CL CL:0000084 MONDO:0008383 SHOULD UBERON:0001977 sex PATO:0000383 ALL biological replicate CL:0000813 individual synthetic peptide CL:0000540 UBERON:0002113 CL:0000898 COVID organism cell type CL:0000815 UBERON:0001088 MONDO:0005138 PTM age MONDO:0005105 UBERON:0001359 URL PATO:0000461 ancestry category HANCESTRO MONDO:0005180 CL:0000913 UBERON:0002107 depletion MONDO organism part xenograft CL:0000451 NCBI UBERON UBERON:0000178 MONDO:0004989 PO NK"
  },
  {
    "title": "Human Sample Metadata Convention",
    "content": "Human Sample Metadata Convention\n\nStatus of this Convention\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These conventions apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This convention defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata conventions (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Conventions.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g",
    "url": "./conventions/human-metadata.html",
    "section": "Human Metadata Convention",
    "keywords": "compound NCIT:C14174 disease AJCC pregnancy status PD III NCIT:C28076 MONDO:0005148 NCIT:C53556 EFO MONDO:0004979 NCIT:C15632 MONDO:0011122 MONDO:0002050 Ann Arbor stage NCIT:C15329 body mass index sampling time point CHEBI:6801 IMPORTANT NCIT:C14168 NCIT:C14169 HANCESTRO:0006 secondary condition NCIT:C28054 TNM staging NCIT:C53553 prior treatment NCIT:C53555 dose IV tumor grade medication history NCIT:C62723 HANCESTRO:0010 SDRF menopausal status gestational age ID NCIT:C27971 NCIT:C4870 NCIT:C28079 smoking status CHEBI:41774 PR breast cancer subtype NCIT:C18213 ACE sex NCIT:C81327 NCIT:C53554 MONDO:0005044 weight ethnicity NCI individual NCIT:C28077 time post treatment NCIT:C81328 NCIT:C71732 NCIT:C16358 NCIT:C18206 NCIT:C27966 UO organism NCIT:C65106 BMI disease stage NCIT:C65108 alcohol consumption NOTE treatment treatment status diet NCIT:C28078 PREFERRED TNM NCIT:C68804 height NCIT:C27970 HIPAA age NCIT exclamation MONDO:0004995 ancestry category HANCESTRO NCIT:C18058 NCIT:C15262 MONDO NCIT:C15313 HANCESTRO:0009 organism part CHEBI:28748 NCIT:C65107 CHEBI:27899 ER NCIT:C14167 II Dukes stage NCIT:C15445 HANCESTRO:0005 pre-existing condition GDPR MONDO:0005300 treatment response"
  },
  {
    "title": "Human Sample Metadata Convention",
    "content": "Human Sample Metadata Convention\n\nStatus of this Convention\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These conventions apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This convention defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata conventions (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Conventions.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g",
    "url": "./conventions/human-metadata.html#human-sample-metadata-convention",
    "section": "Human Metadata Convention",
    "keywords": "compound NCIT:C14174 disease AJCC pregnancy status PD III NCIT:C28076 MONDO:0005148 NCIT:C53556 EFO MONDO:0004979 NCIT:C15632 MONDO:0011122 MONDO:0002050 Ann Arbor stage NCIT:C15329 body mass index sampling time point CHEBI:6801 NCIT:C14168 NCIT:C14169 HANCESTRO:0006 secondary condition NCIT:C28054 TNM staging NCIT:C53553 prior treatment NCIT:C53555 dose IV tumor grade medication history NCIT:C62723 HANCESTRO:0010 SDRF menopausal status gestational age ID NCIT:C27971 NCIT:C4870 NCIT:C28079 smoking status CHEBI:41774 PR breast cancer subtype NCIT:C18213 ACE sex NCIT:C81327 NCIT:C53554 MONDO:0005044 weight ethnicity NCI individual NCIT:C28077 time post treatment NCIT:C81328 NCIT:C71732 NCIT:C16358 NCIT:C18206 NCIT:C27966 UO organism NCIT:C65106 BMI disease stage NCIT:C65108 alcohol consumption treatment treatment status diet NCIT:C28078 PREFERRED TNM NCIT:C68804 height NCIT:C27970 HIPAA age NCIT MONDO:0004995 ancestry category HANCESTRO NCIT:C18058 NCIT:C15262 MONDO NCIT:C15313 HANCESTRO:0009 organism part CHEBI:28748 NCIT:C65107 CHEBI:27899 ER NCIT:C14167 II Dukes stage NCIT:C15445 HANCESTRO:0005 pre-existing condition GDPR MONDO:0005300 treatment response"
  },
  {
    "title": "Data File Metadata Conventions",
    "content": "Data File Metadata Conventions\n\nStatus of this Convention\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These conventions define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata conventions define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This convention covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata conventions (organism, age, sex, disease), see Sample Metadata Conventions.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\ns",
    "url": "./conventions/data-file-metadata.html",
    "section": "Data File Metadata Convention",
    "keywords": "MGF MT PSI fraction identifier instrument PRIDE:0000663 MOD UNIMOD:4 KR label MS:1001313 scan window upper limit proteomexchange accession number MS:1001303 NOTE AC SHOULD SRM MSD FTP MS:1001251 proteomics data acquisition method HF RECOMMENDED ELISA MS:1001917 RPPA SILAC technical replicate exclamation UNIMOD:21 RAW fragment mass tolerance URL TMT MM SDRF UNIMOD:35 MS2 analyzer type PRM data file modification parameters DIA TOF DDA sample CF TA LTQ MUST MS1 scan range precursor mass tolerance XL PRIDE SCIEX cleavage agent details PP fraction CS ST MS:1001306 UNIMOD ID UNIMOD:737 URI MS:1001309 NT TIP TS MRM file uri REQUIRED MS IMPORTANT scan window lower limit UNIMOD:1"
  },
  {
    "title": "Data File Metadata Conventions",
    "content": "Data File Metadata Conventions\n\nStatus of this Convention\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These conventions define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata conventions define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This convention covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata conventions (organism, age, sex, disease), see Sample Metadata Conventions.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\ns",
    "url": "./conventions/data-file-metadata.html#data-file-metadata-conventions",
    "section": "Data File Metadata Convention",
    "keywords": "MGF MT PSI fraction identifier instrument PRIDE:0000663 MOD UNIMOD:4 KR label MS:1001313 scan window upper limit proteomexchange accession number MS:1001303 AC SHOULD SRM MSD FTP MS:1001251 proteomics data acquisition method HF RECOMMENDED ELISA MS:1001917 RPPA SILAC technical replicate UNIMOD:21 RAW fragment mass tolerance URL TMT MM SDRF UNIMOD:35 MS2 analyzer type PRM data file modification parameters DIA TOF DDA CF TA LTQ MUST MS1 scan range precursor mass tolerance XL PRIDE SCIEX cleavage agent details PP CS ST MS:1001306 UNIMOD ID UNIMOD:737 URI MS:1001309 NT TS MRM file uri REQUIRED MS scan window lower limit UNIMOD:1"
  }
];
